Yes, environmental health and safety considerations are included in drug quality audits in Japan. Regulatory frameworks, such as the Good Manufacturing Practice (GMP) guidelines, emphasize environmental controls and safety measures to ensure product quality and compliance. These audits assess facilities’ adherence to environmental and safety standards, ensuring safe pharmaceutical production.
